CE-Marked CDx kit solution for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and gastrointestinal stromal tumor (GIST).
Detect gene mutations at the standard recommended (TierⅠ and tierⅡ variants) by clinical guidelines, including all the EMA/FDA/NMPA-approved targeted therapy.
With a starting material requirement as low as 30ng, our kits are suitable for small samples such as those obtained from needle biopsies.
Key Features and Benefits

Efficient and Accurate Library Construction

Utilizing Single-Tube-Hybridization, Anti-Contamination-Adapter, and Dual-End-Barcode techniques, the kit ensures rapid and simplified operation, minimizing the risk of contamination while maximizing conversion efficiency.


Intelligent and Efficient Data Analysis

OncoMaster, a comprehensive data analysis system, integrates a robust knowledge base and advanced patented algorithms along with high-performance analysis processes, enabling rapid and efficient data interpretation.


Small in Size, Big on Performance

Despite its compact size of 53kb, the panel covers the vast majority of variants in tierⅠ and tierⅡ associated with lung cancer, colorectal cancer, and gastrointestinal stromal tumors.


Excellent User Experience

The kit’s operation is straightforward and user-friendly, ensuring a seamless experience for all users. Equipped with the fully automated library preparation system, Nexus BR, NGS detection becomes even more convenient.


Performance Validations





Accuracy
117 clinical samples and commercial references With an accuracy of 100%,
no missed or false-positive mutations
Specificity
15 benign lung tissues and cell line samples
npa=100%
Biomarker Panels
EGFR
MET
ERBB2
ALK
BRAF
KRAS
ROS1
RET
PIK3CA
NRAS
HRAS
KIT
PDGFRA


Non-small cell lung cancer (NSCLC):
EGFR、ALK、ROS1、RET、MET、ERBB2、BRAF、PIK3CA、KRAS
Colorectal cancer (CRC):
BRAF、PIK3CA、KRAS、NRAS、HRAS
Gastrointestinal stromal tumor (GIST):
KIT、PDGFRA
Specifications



Certification
CE-IVD
Tests/Kit
48
Alteration detected
SNV, Indel, Fusion and CNV
Sample type
FFPE tissue
Sequencing Type
PE150
Sequencer
Illumina MiSeq
Contact Our Biopharma Team to Learn More
Biomarker Discovery & Translational Research
Clinical Trial Design & Patient Recruitment
Global Capabilities for Clinical Studies
CDx Development & Commercialization
Genomic Data Solutions
ctDNA Monitoring Portfolio
Other
I also want to receive general marketing communications from Burning Rock Dx in addition to the specific information requested here. You may unsubscribe from receiving such general marketing communications at any time.
*Required
By submitting this form, or by checking the box above the “Submit” button (if applicable), you agree that your information will be processed according to Burning Rock’s privacy policy to provide you with the information and/or general marketing communications (if applicable) you have requested here. Burning Rock Dx is committed to protecting and respecting your privacy.
Contact Our Experts
We would like to collect certain personal information about you through cookies and similar technologies in order to personalize the site for you, improve the performance of the site, and support our marketing efforts. By clicking “Accept All”, you confirm that we have your consent to collect and process your personal information in accordance with our Privacy Policy, which may include online targeted and social media advertising in some instances. You can by clicking “Reject All”, you can reject all cookies except for Strictly Necessary Cookies."